Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard G. Lizambri
Richard G. Lizambri
Medicine
Immunology
Asthma
Adverse effect
CD23
4
Papers
163
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Results of a phase II, multiple-dose, randomized trial of an anti-CD23 monoclonal antibody (IDEC-152) in patients with seasonal allergic rhinitis
2003
The Journal of Allergy and Clinical Immunology
Thomas B. Casale
William W. Busse
Richard G. Lizambri
Phillip E. Korenblat
W.F. Schoenwetter
John M. Weiler
Lanny J Rosenwasser
Anjuli Nayak
R.M. Perea
Mark Totoritis
Show All
Source
Cite
Save
Citations (17)
Allergic asthma and an anti-CD23 mAb (IDEC-152)
2003
The Journal of Allergy and Clinical Immunology
Lanny J Rosenwasser
William W. Busse
Richard G. Lizambri
Teresa A Olejnik
Mark Totoritis
Show All
Source
Cite
Save
Citations (3)
Allergic asthma and an anti-CD23 mAb (IDEC-152): Results of a phase I, single-dose, dose-escalating clinical trial
2003
The Journal of Allergy and Clinical Immunology
Lanny J Rosenwasser
William W. Busse
Richard G. Lizambri
Teresa A Olejnik
Mark Totoritis
Show All
Source
Cite
Save
Citations (109)
Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody
2002
Journal of The American Academy of Dermatology
Alice B. Gottlieb
Mark Lebwohl
Mark Totoritis
Ahsan A. Abdulghani
Steve R. Shuey
Patrícia Romano
Umesh Chaudhari
Roberta S. Allen
Richard G. Lizambri
Show All
Source
Cite
Save
Citations (34)
1